Mostrando 2,061 - 2,080 Resultados de 726,717 Para Buscar '"Switzerland"', tiempo de consulta: 1.38s Limitar resultados
  1. 2061
    “…Methods: This is a retrospective, population-based study regarding duration of antibiotic therapy for suspected EOS in Central Switzerland between 2014 and 2018. All neonates >34 0/7 weeks of gestational age started on antibiotic therapy for suspected EOS within the first 3 calendar days of life were included. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 2062
  3. 2063
  4. 2064
    “…This report builds upon a questionnaire survey as part of the national Paediatric End-of-LIfe CAre Needs in Switzerland (PELICAN) study. METHODS: One part of the PELICAN study was set up to assess and explore the parental perspectives on their child’s EOL care. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 2065
  6. 2066
    “…This study aims to describe associations between SES and health service utilization in adults with spinal cord injury from Switzerland. METHODS: We use cross-sectional data from 1,294 participants of the Swiss Spinal Cord Injury Cohort Study community survey 2017. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 2067
  8. 2068
    por Bennett, Sophia Elizabeth
    Publicado 2016
    “…Her Excellency Ms Anna Korka Ambassador Permanent Representative of Greece to the United Nations Office at Geneva and other international organisations in Switzerland; Also present: Deputy Permanent Representative I. …”
    Enlace del recurso
  9. 2069
  10. 2070
  11. 2071
    “…RESULTS: Estimated total annual cost savings for each patient transitioned from ZA to denosumab varied by country and cancer type, ranging from €1583 to €2375 in Austria, from €1980 to €2319 in Sweden (9.1 SEK/€) and from €3408 to €3857 in Switzerland (1.2 CHF/€). Cost savings were mainly driven by the lower SRE related costs and lower administration costs of denosumab compared with ZA. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 2072
  13. 2073
  14. 2074
    “…METHODS: This real world, cross-sectional study enrolled patients over a 3-month period through oncologists across Switzerland. Patients were ≥ 18 years, had solid tumors and at least one bone metastasis, and received routine care for bone metastases. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 2075
  16. 2076
    “…This publication describes the protocol concerning a large cohort of UASMs settled in Switzerland in 2015–2016. Our aim is to assess their health status and examine their trajectories of healthcare services utilisation during the 3-year period after their initial health control. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 2077
    Publicado 1979
    Procedimiento de la Conferencia Libro
  18. 2078
    Publicado 1981
    Procedimiento de la Conferencia Libro
  19. 2079
  20. 2080
Herramientas de búsqueda: RSS